Researchers conducted a study among women to examine the intersection of vaginitis and sexually transmitted infections, including chlamydia and gonorrhea.

The global vaginitis treatment drug market is on a robust growth trajectory, with its valuation projected to leap from USD ...

Estrodiol vaginal inserts are indicated for the treatment of atrophic vaginitis due to menopause. The approved product had a market value of approximately $268 million for the 12 months ending ...

The Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy) drugs in development market research report provides comprehensive information on the therapeutics under development ...